Table of Contents
<< Previous Issue | Jun 2005 (Vol: 2005, Issue: 60) | Next Issue >> |
- Section: Business Commentaries
-
Supply and Demand Will Shape the Future of Equity-Based Transactions
- Section: Deal Trackers
-
Symlin (pramlintide)
- Section: Distribution & Marketing
-
Kos strengthens Cardiovascular Portfolio as Biovail Restructures
- Section: Features
-
Novartis Chooses the UK for High-Value COPD Alliance
-
Dividing Opinion: Shire's Move to Purchase TKT
-
Generics Companies: Moving Up the Food Chain
-
Therapy Focus: Cancer Vaccines
- Section: General
-
BMS Out-Licenses Two Early-Stage Drugs
-
Arakis Ltd
- Section: Licensing
-
Genmab Licenses Preclinical-Stage Antibody to Serono
- Section: Mergers & Acquisitions
-
Genzyme Offers US$600 M for Bone Care
-
GlaxoSmithKline Agrees to Buy Biopharmaceutical Company Corixa
- Section: Research & Development
-
BioGeneriX to Develop Second Protein Using Neose’s GlycoPEGylation(TM) Technology
-
AVANIR Pharmaceuticals Lands Research Deal with Novartis